$20 billion merger collapses after hedge fund attack


Business News - Opportunities - Reviews



$20 billion merger collapses after hedge fund attack – Oct. 27, 2017


Swiss chemicals giant Clariant and its U.S. rival Hunstman have axed their $20 billion merger after it came under attack from an activist investor group.

The two companies said Friday that they decided call the deal off because of doubts that Clariant (CLZNF) would be able to get the backing of enough shareholders to push the deal through.

‘; var storytext = document.getElementById(‘storytext’); var heightToSkip = 0; function resetValues() { totalHeight = 0; targetChildElement = null; }
// Check if story is in the blacklist of articles to remove smartassets // [2017.07.27] Results of a one-off request from r.barbieri if(BLACKLIST[location.pathname] === true) { return } if(storytext == null) { console.log(“Error finding storytext element for SA embed”); return; } for ( i = 0; i 0) { heightToSkip -= storytext.childNodes[i].clientHeight; resetValues(); } else if(heightToSkip minHeight && targetChildElement != null) { //console.log(“total height = ” + totalHeight); //console.log(“childNode = ” + targetChildElement); storytext.childNodes[targetChildElement].insertAdjacentHTML(‘afterend’, smartAssetDiv); smartasset = document.getElementById(‘smartasset-article’); smartasset.style.float = ‘left’; // allows module to have text float to right smartasset.style.marginRight =’20px’; smartasset.style.marginBottom =’25px’; //console.log(storytext.childNodes[targetChildElement]); //SMARTASSET.setDivIndex(targetChildElement); SMARTASSET.setSmartAssetScript(); /* bail out since we’re done */ break; } } /* div with id=”smartassetcontainer”. Sanity check to only embed once */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘div’ && storytext.childNodes[i].id !== “undefined” && storytext.childNodes[i].id === “smartassetcontainer”) { break; } /* div with id=”ie_column” */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘div’ && storytext.childNodes[i].id !== “undefined” && storytext.childNodes[i].id === “ie_column”) { resetValues(); } /* embeds from twitter, facebook, youtube */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘div’ && storytext.childNodes[i].classList.contains(’embed’)) { resetValues(); } /* cnn video player */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘div’ && storytext.childNodes[i].classList.contains(‘cnnplayer’)) { resetValues(); } /* images */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘img’) { resetValues(); } /* images stored in figure tags */ else if (storytext.childNodes[i].nodeName.toLowerCase() === ‘figure’) { if(storytext.childNodes[i].clientWidth

Clariant shares dropped about 5% following the announcement.

The deal was undermined by White Tale Holdings, an activist investor who vocally opposed the merger and bought up Clariant shares in an effort to derail it.

White Tale, a partnership between hedge funds Corvex and 40 North, now claims to be the Swiss chemical giant’s biggest shareholder.

Related: The battle for the future of Tide

“The proposed transaction has no strategic merit,” White Tale wrote in a letter published last month. “It both significantly destroys existing Clariant shareholder value and prevents Clariant from pursuing multiple alternative and immediate opportunities to unlock value for its shareholders.”

Its opposition to the deal is now being supported by other shareholders as well, Clariant and Huntsman (HUN) said.

Clariant announced on Friday that White Tale had increased its stake in the company to more than 20%. The investor’s stake was at 15% last month when it launched its attack on the merger.

CNNMoney (New Delhi) First published October 27, 2017: 4:02 AM ET


Business News - Opportunities - Reviews



Leave a Reply